Sponsor or institution
Clinical trials and research at Agenebio, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $2.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
GABA-A alpha-5 modulator to help memory and thinking in early Alzheimer’s stages
A new, oral drug aimed at soothing overactive brain circuits may help memory and thinking in people at early risk of developing Alzheimer’s dementia.
-
Developing a new treatment for Mild Cognitive Impairment in Alzheimer's Disease
This study is testing a new medication called BPN-27473 to see if it can help people with Mild Cognitive Impairment from Alzheimer's Disease by calming down certain brain areas to improve memory and thinking skills.
-
Oral drug to calm hippocampus overactivity and improve memory in early Alzheimer’s
An oral medication is being developed to reduce overactive brain circuits in the hippocampus and help adults with mild cognitive impairment from Alzheimer’s disease remember better.
-
Developing a new treatment for Mild Cognitive Impairment in Alzheimer's Disease
This study is testing a new oral medication called BPN-27473 to see if it can help improve memory and thinking skills in people with Mild Cognitive Impairment due to Alzheimer's Disease, offering hope for those who currently have limited treatment options.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.